Total raised
—
Stage
Pre-Funding
Founded
2015
Headcount
1-10
HQ
—
Sector
Health Tech & Life Sciences
About
Molecula Maxima is developing a programming environment for the creation of new genetically modified organisms and drugs. Its goal is to make the synthetic biology field accessible to software developers and engineers. Engineers can use Molecula Maxima's Synthetic bioprogramming language and the Cytostudio IDE to design, debug, compile, and optimize chemically synthesized genes.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
software-applicationsgenetic-engineeringgenomicsbioinformaticslaboratoriespharma-companies